Comments
Loading...
Novartis Earnings Estimates, EPS & Revenue | NYSE:NVS | Benzinga
Novartis reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Apr 29
EPS Estimate
$1.830
Quarterly Revenue Estimate
$12.67B
Annual Revenue
(as of Dec 31)
(as of Dec 31)
$51.72B
Analyze the earnings history of Novartis using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| NVS | Novartis | $1.80 | $1.83 | — | — | $11.83B | $12.67B | — | — | 04/29/2025 | Get Alert |
| NVS | Novartis | $1.53 | $1.79 | $1.98 | 10.61% | $11.42B | $12.77B | $13.15B | 3.00% | 01/31/2025 | Get Alert |
| NVS | Novartis | $1.74 | $1.96 | $2.06 | 5.10% | $11.78B | $12.70B | $12.82B | 0.97% | 10/29/2024 | Get Alert |
| NVS | Novartis | $1.83 | $1.86 | $1.97 | 5.91% | $11.44B | $12.28B | $12.51B | 1.89% | 07/18/2024 | Get Alert |
| NVS | Novartis | $1.71 | $1.69 | $1.80 | 6.51% | $12.95B | $11.48B | $11.83B | 3.04% | 04/23/2024 | Get Alert |
| NVS | Novartis | $1.52 | $1.68 | $1.53 | -8.93% | $12.69B | $11.56B | $11.42B | -1.19% | 01/31/2024 | Get Alert |
| NVS | Novartis | $1.58 | $1.70 | $1.74 | — | $12.54B | $11.40B | $11.78B | 3.35% | 10/24/2023 | Get Alert |
| NVS | Novartis | $1.56 | $1.66 | $1.83 | — | $12.78B | $13.17B | $13.62B | 3.42% | 07/18/2023 | Get Alert |
| NVS | Novartis | $1.46 | $1.55 | $1.71 | 10.32% | $12.53B | $12.64B | $12.95B | 2.48% | 04/25/2023 | Get Alert |
| NVS | Novartis | $1.40 | $1.44 | $1.52 | 5.56% | $13.23B | $13.13B | $12.69B | -3.35% | 02/01/2023 | Get Alert |
| NVS | Novartis | $1.71 | $1.57 | $1.58 | 0.64% | $13.03B | $12.99B | $12.54B | -3.44% | 10/25/2022 | Get Alert |
| NVS | Novartis | $1.66 | $1.52 | $1.56 | 2.63% | $12.96B | $13.01B | $12.78B | -1.76% | 07/19/2022 | Get Alert |
| NVS | Novartis | $1.52 | $1.44 | $1.46 | 1.39% | $12.41B | $12.73B | $12.53B | -1.56% | 04/26/2022 | Get Alert |
| NVS | Novartis | $1.34 | $1.42 | $1.40 | -1.41% | $12.77B | $13.30B | $13.23B | -0.53% | 02/02/2022 | Get Alert |
| NVS | Novartis | $1.52 | $1.65 | $1.71 | 3.64% | $12.26B | $13.03B | $13.03B | 0.00% | 10/26/2021 | Get Alert |
| NVS | Novartis | $1.36 | $1.52 | $1.66 | 9.21% | $11.35B | $12.51B | $12.96B | 3.57% | 07/21/2021 | Get Alert |
| NVS | Novartis | $1.56 | $1.59 | $1.52 | -4.40% | $12.28B | $12.51B | $12.41B | -0.79% | 04/27/2021 | Get Alert |
| NVS | Novartis | $1.32 | $1.36 | $1.34 | -1.47% | $12.40B | $12.87B | $12.77B | -0.78% | 01/26/2021 | Get Alert |
| NVS | Novartis | $1.41 | $1.45 | $1.52 | 4.83% | $12.17B | $12.53B | $12.26B | -2.16% | 10/27/2020 | Get Alert |
| NVS | Novartis | $1.34 | $1.35 | $1.36 | 0.74% | $11.76B | $12.00B | $11.35B | -5.44% | 07/21/2020 | Get Alert |
| NVS | Novartis | $1.21 | $1.36 | $1.56 | 14.71% | $11.11B | $12.03B | $12.28B | 2.10% | 04/28/2020 | Get Alert |
Novartis (NVS) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-01-31 | $1.98 | $1.79 | 10.6 % |
| Q3 | 2024-10-29 | $2.06 | $1.96 | 5.10 % |
| Q2 | 2024-07-18 | $1.97 | $1.86 | 5.91 % |
| Q1 | 2024-04-23 | $1.80 | $1.69 | 6.51 % |
Novartis (NVS) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-01-31 | $13.15B | $12.77B | 3.00 % |
| Q3 | 2024-10-29 | $12.82B | $12.70B | 0.97 % |
| Q2 | 2024-07-18 | $12.51B | $12.28B | 1.89 % |
| Q1 | 2024-04-23 | $11.83B | $11.48B | 3.04 % |
FAQ
When is Novartis (NYSE:NVS) reporting earnings?
Novartis (NVS) is scheduled to report earnings on April 29, 2025. The last reported earnings were for reported on January 31, 2025 for Q4.
What were the latest earnings per share (EPS) for Novartis (NYSE:NVS)?
The Actual EPS was $1.98, which beat the estimate of $1.79.
What were Novartis’s (NYSE:NVS) revenues?
The Actual Revenue was $13.2B, which beat the estimate of $12.8B.
Browse earnings estimates, EPS, and revenue on all stocks.